Company Overview
- Headquarters
- 3115 Merryfield Row 120, San Diego CA
- Website
- gossamerbio.com
- Phone
- (858) 684-1300
- Employees
- 172
- Founded in
- 2017
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 54 CompaniesNAICS Code 5417 CompaniesNAICS Code 54171 CompaniesNAICS Code 541 CompaniesNAICS Code 42421 CompaniesNAICS Code 424 CompaniesNAICS Code 4242 CompaniesNAICS Code 541711 CompaniesNAICS Code 42 Companies
- SIC Code
-
SIC Code 283 CompaniesSIC Code 28 Companies
Financials & Stats
Revenue
$63B
Total Funding Amount
$120M
Who is Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company headquartered in San Diego, California. The company employs 172 people and generated $62.5 million in revenue. Gossamer Bio's mission is to develop and commercialize innovative therapies for patients in need. Gossamer Bio is dedicated to the development and commercialization of seralutinib, a potential treatment for pulmonary arterial hypertension (PAH). PAH is a serious condition that affects the arteries in the lungs, making it difficult for the heart to pump blood. Gossamer Bio distinguishes itself through its commitment to providing therapies that address unmet medical needs. The company's focus on seralutinib and PAH reflects their dedication to improving the lives of patients facing this challenging disease. For more information or to learn about investment opportunities, visit Gossamer Bio's website: gossamerbio.com.
Company Leadership
Gossamer Bio Industry Tags
Gossamer Bio Tech Stack
Companies Similar to Gossamer Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Gossamer Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 58M | 11 | Burlingame, CA | 2001 | |
| 54M | 80 | San Diego, CA | 2013 | |
| 53M | 73 | Baltimore, MD | 1990 | |
| 53M | 12 | New York City, NY | ||
| 52M | 92 | Waltham, MA | 1989 |